The Platform Where CDMO Partnerships Begin and Thrive

Eastern GMP Consulting, LLC is an independent pharmaceutical and biotechnology consultancy based in North Wales, Pennsylvania, USA. The firm supports drug developers across CMC, technical operations, and quality functions, with a service focus on CDMO/CMO/CPO/CRO vendor selection and management, CMC project and program management, process development and technology transfer for both small and large molecules, and validation of equipment, processes, and packaging. Additional areas include clinical and commercial packaging, serialization, supply chain management, post-launch technical services, and regulatory and quality compliance support. This is led by a principal with three decades of industry experience in technical operations, CMC project leadership, and senior process validation roles at large pharmaceutical organisations.

PeptiStar Inc.

Japan

PeptiStar is a Japan-based CDMO specializing in the development and cGMP manufacture of peptide and oligonucleotide APIs. From its 10,500 m² R&D and manufacturing site in Settsu, Osaka, the company supports programs from milligram-scale research material through clinical and commercial production. PeptiStar works with complex peptide structures, including long-chain, cyclic, branched and constrained peptides, non-natural amino acids and peptide conjugates. Its route-flexible manufacturing platform includes conventional and microwave-assisted SPPS, STag-PS and SYNCSOL liquid-phase technologies. Integrated downstream capabilities include preparative and continuous chromatography, membrane concentration and lyophilization, with 300 L filter reactors, chromatography columns up to 450 mm and lyophilizers up to 500 L. Purification and subsequent processing are conducted in Class 100,000 controlled areas. PeptiStar also develops and manufactures oligonucleotide APIs and peptide–oligonucleotide conjugates. The company was recognised by Exelixis as its 2025 CDMO of the Year.